Home > Insider Trading > Filing (0001022079-17-000150)

Filing Details

Accession Number:: 0001022079-17-000150
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-06-21 16:27:22
Reporting Period:: 2017-06-19

Filing Date:: 2017-06-21
Accepted Time:: 2017-06-21 16:27:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1022079	Quest Diagnostics Inc	DGX	Services-Medical Laboratories (8071)	161387862

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1520897	T. Catherine Doherty	C/O Quest Diagnostics Incorporated 3 Giralda Farms Madison NJ 07940	Svp, Group Exec. Clin. Fran.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-06-19	9,167	$57.35	78,582	No	4	M	Direct
Common Stock	Acquisiton	2017-06-19	44,000	$57.61	122,582	No	4	M	Direct
Common Stock	Acquisiton	2017-06-19	6,595	$56.12	129,177	No	4	M	Direct
Common Stock	Disposition	2017-06-19	8,852	$107.54	120,325	No	4	S	Direct
Common Stock	Disposition	2017-06-19	315	$108.16	120,010	No	4	S	Direct
Common Stock	Disposition	2017-06-19	42,636	$107.52	77,374	No	4	S	Direct
Common Stock	Disposition	2017-06-19	1,364	$108.14	76,010	No	4	S	Direct
Common Stock	Disposition	2017-06-19	6,418	$107.54	69,592	No	4	S	Direct
Common Stock	Disposition	2017-06-19	177	$108.15	69,415	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2017-06-19	9,167	$57.35	9,167	$57.35
Common Stock	Stock Options (Right to Buy)	Disposition	2017-06-19	44,000	$57.61	44,000	$57.61
Common Stock	Stock Options (Right to Buy)	Disposition	2017-06-19	6,595	$56.12	6,595	$56.12

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2021-05-16	No	4	M	Direct
2022-02-27	No	4	M	Direct
2023-02-25	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,780	Indirect	401(k)/SDCP

Footnotes

This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017.
This transaction was executed in multiple trades at prices ranging from $107.14 to $108.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $108.15 to $108.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $107.12 to $108.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $108.12 to $108.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
The options vested in three annual installments beginning with the first on May 16, 2012, the second on May 16, 2013 and the final on May 16, 2014.
The options vested in three annual installments beginning with the first on February 27, 2013, the second on February 27, 2014 and the final on February 27, 2015.
The options vested in three annual installments beginning with the first on February 25, 2014, the second on February 25, 2015 and the final on February 25, 2016.